Anti-cardiolipin and other anti-phospholipid antibodies in critically ill COVID-19 positive and negative patients

Uriel Trahtemberg, Robert Rottapel, Claudia C dos Santos, Arthur S. Slutsky, Andrew J Baker, Marvin J Fritzler on behalf of the COVID19 Longitudinal Biomarkers of Lung Injury (COLOBILI) group.
doi: https://doi.org/10.1101/2021.02.19.21252113

Article usage

Article usage: February 2021 to July 2025

AbstractFullPdf
Feb 2021350098
Mar 20216894191
Apr 2021356960
May 2021448857
Jun 20217961249
Jul 2021803952
Aug 20211581325
Sep 202157319
Oct 202157428
Nov 202154317
Dec 20215207
Jan 20222967
Feb 20222545
Mar 202229210
Apr 20223105
May 202217111
Jun 202224065
Jul 202218157
Aug 20222117
Sep 202230218
Oct 20222905
Nov 20222013
Dec 20222037
Jan 20231729
Feb 202311311
Mar 20231802
Apr 20232618
May 20231073
Jun 2023845
Jul 2023915
Aug 202315155
Sep 20231376
Oct 20231211
Nov 202321106
Dec 20231022
Jan 20241027
Feb 20241842
Mar 20241754
Apr 2024685
May 2024902
Jun 20242257
Jul 2024702
Aug 2024939
Sep 202424139
Oct 2024969
Nov 202410210
Dec 20241528
Jan 20251449
Feb 20254132
Mar 2025271710
Apr 20251747
May 202520159
Jun 202524207
Jul 2025121
Back to top
Posted February 23, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Anti-cardiolipin and other anti-phospholipid antibodies in critically ill COVID-19 positive and negative patients
Uriel Trahtemberg, Robert Rottapel, Claudia C dos Santos, Arthur S. Slutsky, Andrew J Baker, Marvin J Fritzler
medRxiv 2021.02.19.21252113; doi: https://doi.org/10.1101/2021.02.19.21252113
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area